601 related articles for article (PubMed ID: 9179530)
1. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
2. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
3. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate for the adjunctive treatment of alcohol dependence.
Overman GP; Teter CJ; Guthrie SK
Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
[TBL] [Abstract][Full Text] [Related]
5. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
7. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
8. Acamprosate: A Review of Its Use in Alcohol Dependence.
Plosker GL
Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate in the treatment of alcohol dependence.
Mason BJ
Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
[TBL] [Abstract][Full Text] [Related]
10. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
Gual A; Lehert P
Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
[TBL] [Abstract][Full Text] [Related]
12. Acamprosate produces its anti-relapse effects via calcium.
Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
[TBL] [Abstract][Full Text] [Related]
13. The clinical pharmacology of acamprosate.
Kalk NJ; Lingford-Hughes AR
Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
[TBL] [Abstract][Full Text] [Related]
14. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
Chick J; Howlett H; Morgan MY; Ritson B
Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
[TBL] [Abstract][Full Text] [Related]
15. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
[TBL] [Abstract][Full Text] [Related]
16. The development of acamprosate as a treatment against alcohol relapse.
Kufahl PR; Watterson LR; Olive MF
Expert Opin Drug Discov; 2014 Nov; 9(11):1355-69. PubMed ID: 25258174
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.
al Qatari M; Bouchenafa O; Littleton J
Alcohol Clin Exp Res; 1998 Jun; 22(4):810-4. PubMed ID: 9660305
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate. Pharmacoeconomic implications of therapy.
Foster RH; McClellan KJ
Pharmacoeconomics; 1999 Dec; 16(6):743-55. PubMed ID: 10724798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
